nach oben

Erschienen in:

01.10.2015 | Clinical trial

Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer

verfasst von: G. Vugts, A. J. G. Maaskant-Braat, A. C. Voogd, Y. E. A. van Riet, E. J. T. Luiten, E. J. Th. Rutgers, H. J. T. Rutten, R. M. H. Roumen, G. A. P. Nieuwenhuijzen

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Most patients with locally recurrent breast cancer undergo axillary lymph node dissection (ALND). However, repeat sentinel node biopsy (SNB) could provide regional nodal staging and obviate the need for standard ALND. The Sentinel Node and Recurrent Breast Cancer (SNARB) study is a Dutch nationwide registration study conducted to determine feasibility, aberrant drainage rates, and clinical consequences of repeat SNB. A total of 536 patients with locally recurrent non-metastatic breast cancer underwent lymphatic mapping and repeat SNB in 29 Dutch hospitals. A repeat sentinel node (SN) was identified in 333 of 536 patients (62.1 %) and surgically harvested in 287 patients (53.5 %). Aberrant lymph drainage was observed in 180 (54.1 %) of the 333 patients, more often after previous ALND (81.9 %) than SNB (28.4 %; P < 0.001). In 230 patients (80.1 %), the retrieved SN was tumor negative; 17 SNs (5.9 %) contained a micrometastasis and 29 (10.1 %) a macrometastasis. Confirmation ALND in 31 repeat SN-negative patients revealed a macrometastasis in two patients (6.5 %). The negative predictive value (NPV) of repeat SNB was 93.6 %, and ALND was omitted in 109 of the 248 patients (44.0 %) with a negative repeat SN. In 29 of the 44 patients (63.0 %) with a positive SN, adjuvant treatment plans were altered based on the repeat SNB. Repeat SNB is a feasible procedure with a high NPV, leading to a change in management in a substantial proportion of patients. Therefore, repeat SNB should replace routine ALND and serve as the standard of care in recurrent breast cancer.

NABON (2012) Richtlijn behandeling van het mammacarcinoom. Available at: www.oncoline.nl

Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720CrossRefPubMed

Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349(9069):1864–1867CrossRefPubMed

Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3):394–399 (discussion 9–401) PubMedCentralCrossRefPubMed

Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106(1):4–16CrossRefPubMed

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7(12):983–990CrossRefPubMed

Maaskant AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Tutein Nolthenius-Puylaert MC, Nieuwenhuijzen GA (2009) Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 113(1):173–179CrossRefPubMed

Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E et al (2003) Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 95(20):1514–1521CrossRefPubMed

Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New Engl J Med 347(16):1227–1232CrossRefPubMed

10.

Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M et al (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19(6):1688–1697PubMed

11.

Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E et al (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24(13):2028–2037CrossRefPubMed

12.

Recht A, Come SE, Troyan SL, Sadowski NL (2000) Management of recurrent breast cancer. In: Harris J, Lippman M, Morrow M, Osborne CK (eds) Diseases of the breast. Lippincott Williams & Wilkins, Philadelphia, pp 731–748

13.

Derkx F, Maaskant-Braat AJ, van der Sangen MJ, Nieuwenhuijzen GA, van de Poll-Franse LV, Roumen RM et al (2010) Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure. Eur J Surg Oncol 36(7):646–651CrossRefPubMed

14.

Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME et al (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29(4):341–350CrossRefPubMed

15.

Roumen RM, Kuijt GP, Liem IH (2006) Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol 32(10):1076–1081CrossRefPubMed

16.

Port ER, Garcia-Etienne CA, Park J, Fey J, Borgen PI, Cody HS 3rd (2007) Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 14(8):2209–2214CrossRefPubMed

17.

Intra M, Trifiro G, Galimberti V, Gentilini O, Rotmensz N, Veronesi P (2007) Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg 94(10):1216–1219CrossRefPubMed

18.

Intra M, Viale G, Vila J, Grana CM, Toesca A, Gentilini O et al (2014) Second axillary sentinel lymph node biopsy for breast tumor recurrence: experience of the European Institute of Oncology. Ann Surg Oncol 22:2372–2377CrossRefPubMed

19.

Maaskant-Braat AJ, Roumen RM, Voogd AC, Pijpers R, Luiten EJ, Rutgers EJ et al (2013) Sentinel node and recurrent breast cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol 20(2):620–626CrossRefPubMed

20.

Maaskant-Braat AJ, Voogd AC, Roumen RM, Nieuwenhuijzen GA (2013) Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat 138(1):13–20CrossRefPubMed

21.

Suami H, Pan WR, Taylor GI (2009) Historical review of breast lymphatic studies. Clin Anat 22(5):531–536CrossRefPubMed

22.

Grant RN, Tabah EJ, Adair FE (1953) The surgical significance of the subareolar symph plexus in cancer of the breast. Surgery 33(1):71–78PubMed

23.

Suami H, Pan WR, Mann GB, Taylor GI (2008) The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol 15(3):863–871PubMedCentralCrossRefPubMed

24.

Mukesh MB, Harris E, Collette S, Coles CE, Bartelink H, Wilkinson J et al (2013) Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials. Radiother Oncol 108(2):293–298CrossRefPubMed

25.

Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J et al (1994) Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30(5):1073–1081CrossRefPubMed

26.

Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF et al (2006) Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 7(3):248–253CrossRefPubMed

27.

Dinan D, Nagle CE, Pettinga J (2005) Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery. Am J Surg 190(4):614–617CrossRefPubMed

28.

Koizumi M, Koyama M, Tada K, Nishimura S, Miyagi Y, Makita M et al (2008) The feasibility of sentinel node biopsy in the previously treated breast. Eur J Surg Oncol 34(4):365–368CrossRefPubMed

29.

Taback B, Nguyen P, Hansen N, Edwards GK, Conway K, Giuliano AE (2006) Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol 13(8):1099–1104CrossRefPubMed

30.

Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F et al (2004) Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22(1):97–101CrossRefPubMed

31.

Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher ER (1981) Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 48(8):1863–1872CrossRefPubMed

32.

Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. New Engl J Med 347(8):567–575CrossRefPubMed

33.

van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F et al (1999) Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 35(1):32–38CrossRefPubMed

34.

Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ et al (2005) Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41(17):2637–2644CrossRefPubMed

35.

Aebi S, Gelber S, Anderson SJ, Lang I, Robidoux A, Martin M et al (2014) Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol 15(2):156–163PubMedCentralCrossRefPubMed

36.

van der Sangen MJ, Poortmans PM, Scheepers SW, Lemaire BM, van Berlo CL, Tjan-Heijnen VC et al (2013) Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer. Eur J Surg Oncol 39(8):892–898CrossRefPubMed

37.

van der Sangen MJ, van de Poll-Franse LV, Roumen RM, Rutten HJ, Coebergh JW, Vreugdenhil G et al (2006) The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol 32(1):34–38CrossRefPubMed

Titel: Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer
verfasst von: G. Vugts
A. J. G. Maaskant-Braat
A. C. Voogd
Y. E. A. van Riet
E. J. T. Luiten
E. J. Th. Rutgers
H. J. T. Rutten
R. M. H. Roumen
G. A. P. Nieuwenhuijzen
Publikationsdatum: 01.10.2015
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2015
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-015-3571-4

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer

Abstract

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome

Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer

Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

False-negative rate of combined mammography and ultrasound for women with palpable breast masses

Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie